Biopharma bites: Layoffs at Ultragenyx, Gilead's licensing deal, plus a pair of PIPEs and a 340B update

FirstWord Pharma·Feb 13

This story is reported by FirstWord Pharma. Read what other outlets are saying below, then open the original report for full details.